FSTL1 represents another CAF mediator with prometastatic ability, as illustrated by the elevated intrahepatic and lung metastasis in mice engrafted with HCC cells cultured in FSTL1-overexpressing CM and the reversed phenotypes in response to FSTL1 blockade.83 This evidence concerns the gene FSTL1 and hepatocellular carcinoma.